Pfizer to Reduce Drug Costs for Medicaid in Trump Deal

In an effort to support President Donald Trump's 'most favored nations' policy, Pfizer Inc. has agreed to lower the prices of its medications for the United States Medicaid insurance program. This information comes from a report published in the Washington Post.

No Comments from Pfizer or the White House

Attempts to get official comments from both the White House and Pfizer were unsuccessful, as neither party responded to the inquiries.